The BMPR2 mutation is associated with abnormal mitochondrial function and insulin metabolism in cardiac myocytes, with enhanced insulin resistance, reduced glucose uptake, and enhanced lipid uptake, resulting in changes in right ventricular lipotoxicity in PAH. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.